Alpha N Acetylglucosaminidase Market Is Likely to Experience a Tremendous Growth by 2029
Alpha N Acetylglucosaminidase Market is anticipated to grow at a significant CAGR during the forecast period. Alpha N acetylglucosaminidase is a protein associated with Sanfilippo syndrome. It is an enzyme with systematic name alpha-N-acetyl-D-glucosaminide N-acetylglucosaminohydrolase. This enzyme is located in lysosomes, compartments within cells that digest and recycle different types of molecules. The major factor attributable to market growth includes the growing prevalence of Sanfilippo syndrome all over the globe. Sanfilippo syndrome is a rare genetic metabolism disorder. A change in a single gene makes a child's body unable to break down certain carbohydrates (sugars). This leads to serious problems in the brain and nervous system. There is no cure yet for Sanfilippo syndrome. However, alpha-N-acetylglucosaminidase is involved in the stepwise breakdown of large molecules known as glycosaminoglycans (GAGs).
GAGs are composed of sugar
molecules that are linked together to form a long string. To break down these
large molecules, individual sugars are removed one at a time from one end of
the molecule. Alpha-N-acetylglucosaminidase removes a sugar called N-acetylglucosamine
when it is at the end of the GAG chain. Another major factor propelling the
growth of the global alpha N acetylglucosaminidase market include the ongoing
clinical trials. Clinically, 3 different phenotypes of
alpha-N-acetylglucosaminidase have been discovered. Type I is an
infantile-onset neuroaxonal dystrophy with rapid neurodegenerative changes
manifested by severe psychomotor retardation, cortical blindness, and myoclonal
seizures. Lesions are limited to the nervous system, however, there is diffuse
osteopenia. Type II is a chronic condition manifested as mild intellectual
retardation, angiokeratoma corporis diffusum, and slight facial features. Type
III is an intermediate form.
To Request a Sample of our Report on Alpha
N Acetylglucosaminidase Market: https://www.omrglobal.com/request-sample/alpha-n-acetylglucosaminidase-market
•
The market number available for – 2022-2030
•
Base year- 2022
•
Forecast period- 2023-2030
Segment
Covered-
·
By Type
·
By Application
Regions covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive
Landscape: Abeona Therapeutics Inc., and BioMarin Pharmaceutical Inc.
among others.
Alpha N
Acetylglucosaminidase Market Report by Segment
By Type
•
Lesinidase Alfa
•
ABO-101
•
BMN-250
•
EGT-201
•
Others
By
Application
•
In-Patient
•
Out-Patient
A full Report of Alpha N Acetylglucosaminidase Market is
Available @ https://www.omrglobal.com/industry-reports/alpha-n-acetylglucosaminidase-market
Alpha N Acetylglucosaminidase
Market Report by Region
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/alpha-n-acetylglucosaminidase-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment